Check out our scientific poster on Joint Involvement and Disease Activity in SLE Patients at EULAR 2020! Click to view more
Collaboration enables otolaryngologists and researchers to leverage data for real-world evidence, outcomes, and personalized medicine programs BOSTON, May 13, 2020 — OM1, a real-world outcomes and technology company, today announced a strategic partnership with the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) connecting the Foundation’s Reg-entSM clinical data registry to OM1’s real-world data[…]
May 28, 2020 11:00 AM – 12:00 PM In the midst of a pandemic, healthcare providers and regulators are hyper-focused on Covid-19. But, moving research forward in other conditions is still critical and does not need to come to a halting stop. Join us as we explore: – Enabling real-world research and registries while healthcare[…]
Tuesday, March 31 – 1:00 – 2:00 pm ET Register The promise of real-world data is driving increased requirements and use. But, what does high-quality RWD actually look like? How should life sciences companies access and use it most effectively? What are the implications when applying RWD to clinical trials, registries, and other evidence and[…]
Published February 28, 2020, HealthEconomics.com – written by Kathryn Starzyk, Senior Director, RWE, OM1 Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations — getting down to ever more precise groups of likely responders to therapy, high-risk patients and[…]
